PNPLA3 and metabolic dysfunction-associated steatotic liver disease: PNPLA3 risk allele c.444G frequency vs. wild-type allele was lower in both controls (12.5 vs. 87.5%) and NAFLD (23.7 vs. 76.3%), consistent with previous reports (24).